Business ❯ Corporate Governance ❯ Investor Relations

Public Companies

Securities Fraud Stock Market Securities Securities Regulations Financial Reporting Stock Performance Securities Offerings Altimmune, Inc. James Hardie Industries Securities Regulation

3 ARTICLES

last wk.

Law Firms Urge Investors to Seek Lead Role in Planet Fitness Securities Suit

The solicitations allege Planet Fitness misled shareholders on marketing, membership trends and its Black Card pricing plan and set up a contested race for lead plaintiff before a September deadline.

5 ARTICLES

last wk.

Securities Suit Filed Against Grail After NHS‑Galleri Readout Misses Primary Endpoint

7 ARTICLES

2mo ago

Multiple Firms Seek Lead Role in Gossamer Bio Securities Suit After PROSERA Miss

4 ARTICLES

3mo ago

Medpace Investors Urged to Seek Lead Role in Securities Suit Before June 8 Deadline

3 ARTICLES

3mo ago

Rosen Law Reminds Stellantis Investors of June 8 Deadline to Seek Lead Role in Securities Suit

4 ARTICLES

3mo ago

Corcept Investors Face Today’s Lead‑Plaintiff Deadline in Securities Case Over Relacorilant Disclosures

5 ARTICLES

3mo ago

Grocery Outlet Investors Urged to Seek Lead-Plaintiff Role by May 15 in Securities Suits

6 ARTICLES

3mo ago

Corcept Investors Face April 21 Deadline to Seek Lead Role in Securities Suit Over Relacorilant

3 ARTICLES

4mo ago

Mereo Investors Face Lead‑Plaintiff Deadline in Securities Suit Over Setrusumab Trials

3 ARTICLES

4mo ago

Securities Suit Targets monday.com Ahead of May 11 Lead‑Plaintiff Deadline

8 ARTICLES

4mo ago

Soleno Hit With Securities Class Action Over Prader‑Willi Drug DCCR

8 ARTICLES

4mo ago

Trip.com Investors Urged to Seek Lead Role in Securities Suit Before May 11 Deadline

7 ARTICLES

4mo ago

Plaintiff Firms Intensify Biotech Securities Suits as Key Deadlines Near for Nektar, uniQure and REGENXBIO

5 ARTICLES

4mo ago

NuScale Sued in Securities Class Action Over ENTRA1 Claims and $495 Million Charge

3 ARTICLES

5mo ago

Mereo BioPharma Investors Face April 6 Deadline in Lawsuits Over Failed Setrusumab Trials

6 ARTICLES

5mo ago

Varonis Investors Urged to Act as March 9 Lead-Plaintiff Deadline Nears in Securities Class Action

5 ARTICLES

5mo ago

Law Firms Urge CoreWeave Investors to Seek Lead Role in Securities Class Action Before March 13

Public Companies

Law Firms Urge Investors to Seek Lead Role in Planet Fitness Securities Suit

GrubMarket Confidentially Files for U.S. IPO

Lime Moves Forward With $181 Million IPO Backed by Uber Interest

Investors Mobilize in Commvault Securities Suit Over Alleged ARR Misstatements

Securities Suit Filed Against Grail After NHS‑Galleri Readout Misses Primary Endpoint

Multiple Firms Seek Lead Role in Gossamer Bio Securities Suit After PROSERA Miss

Medpace Investors Urged to Seek Lead Role in Securities Suit Before June 8 Deadline

Rosen Law Reminds Stellantis Investors of June 8 Deadline to Seek Lead Role in Securities Suit

Corcept Investors Face Today’s Lead‑Plaintiff Deadline in Securities Case Over Relacorilant Disclosures

Grocery Outlet Investors Urged to Seek Lead-Plaintiff Role by May 15 in Securities Suits

Never miss stories about

Public Companies

Corcept Investors Face April 21 Deadline to Seek Lead Role in Securities Suit Over Relacorilant

Mereo Investors Face Lead‑Plaintiff Deadline in Securities Suit Over Setrusumab Trials

Securities Suit Targets monday.com Ahead of May 11 Lead‑Plaintiff Deadline

Soleno Hit With Securities Class Action Over Prader‑Willi Drug DCCR

Trip.com Investors Urged to Seek Lead Role in Securities Suit Before May 11 Deadline

Plaintiff Firms Intensify Biotech Securities Suits as Key Deadlines Near for Nektar, uniQure and REGENXBIO

NuScale Sued in Securities Class Action Over ENTRA1 Claims and $495 Million Charge

Mereo BioPharma Investors Face April 6 Deadline in Lawsuits Over Failed Setrusumab Trials

Varonis Investors Urged to Act as March 9 Lead-Plaintiff Deadline Nears in Securities Class Action

Law Firms Urge CoreWeave Investors to Seek Lead Role in Securities Class Action Before March 13

Never miss stories about

Public Companies